PCOS Renaming: A Call for Prudent Medical Terminology and Responsible Healthcare Spending
The shift from PCOS to PMOS highlights the importance of accurate medical terminology and efficient resource allocation in addressing women's health concerns.

The renaming of polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS), announced at the European Congress of Endocrinology in Prague, raises important questions about the use of medical terminology and the responsible allocation of resources within the healthcare system. While the intention behind the change – to better reflect the condition’s complexities and reduce confusion – is laudable, it is crucial to ensure that such changes are grounded in sound scientific evidence and do not unnecessarily burden the healthcare system.
The term “polycystic,” as noted by experts like Prof. Helena Teede, director of Melbourne’s Monash Centre for Health Research & Implementation, has long been a source of confusion, potentially leading to delayed diagnosis and inadequate medical care. The move to PMOS aims to address this issue by more accurately representing the condition’s broader impact on the endocrine and metabolic systems. However, any changes to established medical terminology should be carefully considered, with a focus on maintaining clarity and avoiding unnecessary disruption to existing medical practices.
One of the primary concerns is the potential cost associated with implementing this change. Updating medical records, retraining healthcare professionals, and revising educational materials all require significant financial investment. It is essential that these expenses are justified by a clear and demonstrable improvement in patient outcomes. Resources should be allocated prudently, prioritizing interventions that offer the greatest benefit to patients while minimizing waste and inefficiency.
Moreover, it is important to recognize that the fundamental principles of healthcare remain unchanged, regardless of the terminology used. The focus should always be on providing individualized care based on the patient’s specific needs and circumstances. This requires a strong emphasis on personal responsibility, healthy lifestyle choices, and a commitment to maintaining one’s overall well-being.
The emphasis on the metabolic aspects of PMOS also underscores the importance of addressing lifestyle factors, such as diet and exercise, in the management of the condition. Encouraging women to adopt healthy habits can significantly reduce their risk of developing related health problems, such as diabetes and cardiovascular disease. Promoting personal responsibility in healthcare is essential for both individual well-being and the long-term sustainability of the healthcare system.

